0 references
Impact of Targeted Posaconazole Prophylaxis in Heart Transplant Recipients During an Outbreak of Early Invasive Aspergillosis
Clinical Transplantation2025Vol. 39(6), pp. e70210–e70210
Malo Penven, Céline Goéminne, Camille Ternynck, Séverine Loridant, Agnès Perrin‐Guyomard, Benjamín Valentín, Karine Faure, Sarah Stabler, Emmanuel Faure, Fanny Vuotto
Abstract
Targeted POS prophylaxis may be an option for high-risk HTR during an outbreak. Close monitoring of liver function, POS levels, and tacrolimus concentrations is recommended.
Related Papers
- → In Vitro and In Vivo Activities of Posaconazole and Amphotericin B in a Murine Invasive Infection by Mucor circinelloides: Poor Efficacy of Posaconazole(2012)45 cited
- → Failure of Posaconazole Therapy in a Renal Transplant Patient with Invasive Aspergillosis Due to Aspergillus fumigatus with Attenuated Susceptibility to Posaconazole(2011)40 cited
- → Efficacy of Posaconazole in a Murine Model of Central Nervous System Aspergillosis(2004)60 cited
- → Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis(2002)42 cited
- → Comparative survival and cost of antifungal therapy: posaconazole versus standard antifungals in the treatment of refractory invasive aspergillosis(2010)9 cited